InspireMD gains FDA approval for carotid stent to expand TCAR market
InspireMD received FDA approval for the CGuard Prime TransCarotid Stent System, expected to approximately double the U.S. addressable market. The company reported continued strong international performance and announced key leadership appointments ahead of the U.S. launch.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed